BioSpace News Archive

Sensorion announces that Federico Mingozzi, Ph.D., is joining the Board of Directors of Sensorion as a Non-Executive Director by way of co-optation.

Asieris Pharmaceuticals announced that the interim analysis data from the Phase II clinical trial of oral APL-1202 in combination with PD-1 inhibitor tislelizumab as neoadjuvant therapy for muscular invasive bladder cancer will be presented for the first time in the form of a rapid oral presentation abstract at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Vera Therapeutics, Inc. today announced positive 72-week data from the open label extension (OLE) period of its Phase 2b ORIGIN clinical trial of atacicept in participants with IgA nephropathy (IgAN). In aggregate, the 72-week data with atacicept are consistent with a profile of true disease modification in IgAN.

RedHill Biopharma Ltd. announced that the U.S. Patent and Trademark Office issued a new patent, U.S. Patent No. 11,878,011, covering Talicia as a method for eradicating Helicobacter pylori regardless of patient Body Mass Index.

Net sales amounted to SEK 155.7 million (131.5), corresponding to an increase of 18 percent in SEK and 16 percent in local currencies.

Leading health insurer and health care services company Humana Inc. announced that it has named David Dintenfass as President of Enterprise Growth.